Skip to Content

TCL 1221 (Nitroglycerin Extended-Release 2.5 mg)

Pill with imprint TCL 1221 is Purple / Clear, Capsule-shape and has been identified as Nitroglycerin Extended-Release 2.5 mg. It is supplied by Major Pharmaceuticals Inc..

Nitroglycerin is used in the treatment of angina; anal fissure and fistula; raynaud's syndrome; heart attack; high blood pressure and belongs to the drug classes antianginal agents, vasodilators. Risk cannot be ruled out during pregnancy. Nitroglycerin 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TCL 1221

Nitroglycerin extended-release 2.5 mg TCL 1221
Nitroglycerin extended-release 2.5 mg TCL 1221
Nitroglycerin extended-release 2.5 mg TCL 1221
Nitroglycerin extended-release 2.5 mg TCL 1221
Nitroglycerin extended-release 2.5 mg TCL 1221

Nitroglycerin Extended-Release

Imprint
TCL 1221
Strength
2.5 mg
Color
Purple / Clear
Size
7.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antianginal agents, Vasodilators
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Major Pharmaceuticals Inc.
National Drug Code (NDC)
00904-0643
Inactive Ingredients
corn starch, ethylcelluloses, gelatin, lactose anhydrous, shellac, acetylated sucrose distearate, magnesium silicate, carnauba wax, FD&C Blue No. 1, D&C Yellow No. 10, D&C Red No. 28

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "TCL 1221"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.